Connection
Kevin Lillehei to Killer Cells, Lymphokine-Activated
This is a "connection" page, showing publications Kevin Lillehei has written about Killer Cells, Lymphokine-Activated.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.079 |
|
|
|
-
Lillehei KO, Johnson SD, McCleary EL, Mitchell DH, Schiltz PM, Kruse CA. Adjuvant adoptive immunotherapy for pediatric recurrent brain tumors. Online J Curr Clin Trials. 1993 Dec 29; Doc No 111:[806 words; 5 paragraphs].
Score: 0.029
-
Lillehei KO, Mitchell DH, Johnson SD, McCleary EL, Kruse CA. Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy. Neurosurgery. 1991 Jan; 28(1):16-23.
Score: 0.023
-
Kruse CA, Mitchell DH, Lillehei KO, Johnson SD, McCleary EL, Moore GE, Waldrop S, Mierau GW. Interleukin-2-activated lymphocytes from brain tumor patients. A comparison of two preparations generated in vitro. Cancer. 1989 Oct 15; 64(8):1629-37.
Score: 0.021
-
Kruse CA, Lillehei KO, Mitchell DH, Kleinschmidt-DeMasters B, Bellgrau D. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take. Proc Natl Acad Sci U S A. 1990 Dec; 87(24):9577-81.
Score: 0.006